ANDA 87619, held by Vangard. Imipramine Hydrochloride.
As of Nov 16, 2026, ANDA 87619 (Imipramine Hydrochloride), held by Vangard, was first approved by FDA on Feb 9, 1982, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 9, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Imipramine Hydrochloride25MG ยท tablet;oral | Imipramine Hydrochloride | Discontinued |
| Feb 27, 1985 | Supplement 3Manufacturing | Approved | None posted |
| Feb 9, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters